Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06374719 · ClinicalTrials.gov registry record
WiTNNess - TNNT1 Myopathy Natural History Study
A clinical trial of Myopathy and TNNT1-associated Myopathy, sponsored by Clinic for Special Children.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06374719 is a study of Myopathy and TNNT1-associated Myopathy that is actively recruiting participants, run by Clinic for Special Children. The registered enrollment target is 40 participants, roughly in line with the 41-participant average among 3 other Myopathy trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06374719, a study of Myopathy and TNNT1-associated Myopathy, is actively recruiting participants, sponsored by Clinic for Special Children.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
WiTNNess is designed to accurately document the natural course and variation of muscle disease caused by pathogenic changes of the TNNT1 gene. The primary aim of the study is to specify meaningful outcome measures for future clinical trials. WiTNNess is open to children and adults worldwide. Participants can choose to include their information once (cross-sectional cohort) or every few months (prospective cohort).
Conditions Studied
Study Locations (1)
Pennsylvania
- Clinic for Special Children - Gordonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-09-23 |
| Est. Completion | 2027-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06374719
The ClinicalTrials.gov registry entry for NCT06374719 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 41-participant average among 3 other Myopathy trials with a reported enrollment target. The listed sponsor is Clinic for Special Children, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Myopathy appearing as the primary indexed condition, and to 0 interventions.
NCT06374719 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06374719 about?
NCT06374719 is a clinical study titled "WiTNNess - TNNT1 Myopathy Natural History Study". WiTNNess is designed to accurately document the natural course and variation of muscle disease caused by pathogenic changes of the TNNT1 gene. The primary aim of the study is to specify meaningful outcome measures for future clinical trials. WiTNNess is open to children and adults worldwide. Partici...
What is the current status of trial NCT06374719?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2018-09-23. Estimated completion is 2027-06-01.
What conditions does trial NCT06374719 study?
This clinical trial studies the following conditions: Myopathy, TNNT1-associated Myopathy, Infantile-onset Nemaline Rod Myopathy, Myopathies, Nemaline, Myopathy, Rod.
Who is sponsoring clinical trial NCT06374719?
This trial is sponsored by Clinic for Special Children, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06374719 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
RECRUITING
-
Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
ACTIVE NOT RECRUITING · NA
-
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.